CONDENSED BALANCE SHEETS - USD ($)	Mar. 31, 2025	Dec. 31, 2024
Current Assets:
Cash and cash equivalents	$ 2,255,815	$ 3,170,743
Trade receivables, net of allowance of $0 and $0, respectively	0	0
Inventories, net	449,798	453,103
Prepaid and other current assets	154,453	89,472
Total current assets	2,860,066	3,713,318
Property, Plant and Equipment:	19,101,096	19,679,918
Accumulated depreciation	(18,883,683)	(19,446,262)
Property, Plant and Equipment, net	217,413	233,656
Other Assets:
Operating lease right-of-use assets, net	1,749,793	1,880,372
Patents, net of accumulated amortization of $137,299 and $137,114 respectively	28,309	28,494
Equity method investment	64,685	62,187
Other non-current assets	1,252,726	1,228,399
Total other assets	3,095,513	3,199,452
Total Assets	6,172,992	7,146,426
Current Liabilities:
Accounts payable	413,147	449,437
Related party payables	11,538	5,769
Accrued expenses	218,017	246,159
Accrued payroll	244,652	192,856
Accrued professional services fees	225,629	222,704
Accrued interest	577,798	565,773
Current portion of operating lease liability	601,673	578,153
Bridge loan		19,555
Total current liabilities	2,292,454	2,280,406
Long-Term Liabilities:
Non-current operating lease liabilities	1,303,220	1,464,872
Accrued warranty liability		21,225
Total liabilities	3,595,674	3,766,503
Commitments and contingencies (Note 17)
Stockholders’ Equity (Deficit):
Series A preferred stock, $.0001 par value; 750,000 shares authorized; 48,100 and 48,100 shares issued and outstanding, respectively ($959,996 and $947,971 Liquidation Preference, respectively)	5	5
Common stock, $0.0001 par value, 500,000,000 authorized; 1,705,977 and 1,454,896 shares issued and outstanding, respectively	171	145
Additional paid in capital	495,852,728	494,983,561
Accumulated deficit	(493,283,006)	(491,608,710)
Accumulated other comprehensive loss	7,420	4,922
Total stockholders’ equity (deficit)	2,577,318	3,379,923
Total Liabilities and Stockholders’ Equity (Deficit)	$ 6,172,992	$ 7,146,426